Osimertinib plus savolitinib in pts with EGFRm MET-amplified/overexpressed NSCLC: Phase Ib TATTON parts B and D final analysis Meeting Abstract
| Authors: | Han, J.; Sequist, L.; Ahn, M.; Cho, B. C.; Yu, H.; Kim, S.; Yang, J. C.; Lee, J. S.; Su, W.; Kowalski, D. M.; Orlov, S.; Cantarini, M.; Ren, S.; Frewer, P.; Ou, X.; Janne, P. |
| Abstract Title: | Osimertinib plus savolitinib in pts with EGFRm MET-amplified/overexpressed NSCLC: Phase Ib TATTON parts B and D final analysis |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | non-small cell lung cancer; osimertinib; savolitinib |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S227 |
| End Page: | S228 |
| Language: | English |
| ACCESSION: | WOS:000631349600297 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.146 |
| Notes: | Meeting Abstract: FP14.03 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
